Beta-adrenergic agonist and muscarinic antagonist compositions and methods of using
AssigneeBonafide Health, LLC
InventorsJames R. Komorowski, Sarah Sylla, Devon Bernsley
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.
Claims22
A composition for supporting bladder health and/or treating overactive bladder or at least one symptom associated therewith comprising an amount of a beta-adrenergic receptor agonist and an amount of at least one muscarinic receptor antagonist, wherein the beta-adrenergic receptor agonist comprises S-adenosyl-L-methionine (SAMe) and wherein the at least one muscarinic receptor antagonist is the Crataeva nurvala plant material or extract thereof and a mixture of black maca and yellow maca, wherein the mixture of black maca and yellow maca comprises a ratio of black maca to yellow maca of about 4:1 to about 1:4.
A composition for supporting bladder health and/or treating overactive bladder or at least one symptom associated therewith comprising an amount of a beta-adrenergic receptor agonist and an amount of at least one muscarinic receptor antagonist, wherein the beta-adrenergic receptor agonist comprises S-adenosyl-L-methionine (SAMe) and propyl gallate (PG), wherein SAMe and PG comprise a mixture having a ratio of SAMe to PG of about 8:1 to about 128:1, and wherein the at least one muscarinic receptor antagonist is selected from the group consisting of pumpkin seed, Crataeva nurvala plant material or an extract thereof, Lindera aggregata plant material or an extract thereof, black maca, yellow maca, phycocyanin or an extract thereof, and any combination thereof.
A dietary supplement comprising an amount of a beta-adrenergic receptor agonist and an amount of at least of one muscarinic receptor antagonist, wherein the beta-adrenergic receptor agonist comprises S-adenosyl-L-methionine (SAMe) and wherein the at least one muscarinic receptor antagonist is Crataeva nurvala plant material or extract thereof and a mixture of black maca and yellow maca, wherein the mixture of black maca and yellow maca comprises a ratio of black maca to yellow maca of about 4:1 to about 1:4.
A dietary supplement comprising an amount of a beta-adrenergic receptor agonist and an amount of at least one muscarinic receptor antagonist, wherein the beta-adrenergic receptor agonist comprises S-adenosyl-L-methionine SAMe) and propyl gallate (PG), wherein SAMe and PG comprise a mixture having a ratio of SAMe to PG of about 8:1 to about 128:1, and wherein the at least one muscarinic receptor antagonist is selected from the group consisting of pumpkin seed, Crataeva nurvala plant material or an extract thereof, Lindera aggregata plant material or an extract thereof, black maca, yellow maca, phycocyanin or an extract thereof, and any combination thereof.
Dependencies are inferred from the claim text.